Filing Flows › Abbott Laboratories (ABT) › Q2 2026
Abbott Laboratories (ABT) Q2 2026 earnings results (second quarter 2026)
10-Q filed Jul 28, 2026
Abbott Laboratories (ABT) reported revenue of $12.6B for the second quarter 2026 (Q2 2026), +13% from a year earlier and +13% from the quarter before. Operating margin was 13.4%, net earnings $928M (7.4% of revenue).
Abbott Laboratories, Q2 2026: revenue $12.6B (+13% year over year), operating margin 13.4%, net earnings $928M, operating cash flow $2.5B. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $12.6B | +13% | +13% |
| Operating profit | $1.7B | +26% | -17% |
| Net earnings | $928M | -14% | -48% |
| Operating cash flow | $2.5B | +89% | +22% |
| Free cash flow | $2.0B | +117% | +29% |
What changed
Revenue was $12.6B in Q2 2026, up 13% year over year and up 13% from the previous quarter.
Operating profit was $1.7B, a 13.4% margin (down 5.0 points year over year). Operating profit fell $0.36B even though revenue rose $1.5B versus Q2 2025, so costs grew faster than sales. Total costs grew 20% against revenue growth of 13%. The fastest-growing cost line was Other operating costs (+57%). Net earnings were $0.93B, down 48% year over year. The effective tax rate was 39.1%.
Operating cash flow was $2.5B (up 22% year over year), 268% of net earnings. Non-cash charges added back $1.1B of depreciation and amortization and $0.17B of share-based compensation. Working capital and other items added $0.33B. Capital expenditures of $0.50B left free cash flow of $2.0B.
Questions
What was Abbott Laboratories' revenue in the second quarter 2026?
Abbott Laboratories (ABT) reported revenue of $12.6B for the second quarter 2026 (Q2 2026), +13% from a year earlier and +13% from the quarter before.
Was Abbott Laboratories profitable in the second quarter 2026?
Operating profit was $1.7B (13.4% of revenue) and net earnings $928M.